Your browser doesn't support javascript.
loading
Advances in Ovarian Cancer Treatment Beyond PARP Inhibitors.
Aliyuda, Fine; Moschetta, Michele; Ghose, Aruni; Sofia Rallis, Kathrine; Sheriff, Matin; Sanchez, Elisabet; Rassy, Elie; Boussios, Stergios.
Afiliación
  • Aliyuda F; Department of Medical Oncology, Medway NHS Foundation Trust, Gillingham, Kent, UK.
  • Moschetta M; Novartis Institutes for BioMedical Research, Basel, Switzerland.
  • Ghose A; Department of Medical Oncology, Medway NHS Foundation Trust, Gillingham, Kent, UK.
  • Sofia Rallis K; Department of Medical Oncology, Barts Cancer Centre, St. Bartholomew's Hospital, Barts Health NHS Trust, London, UK.
  • Sheriff M; Department of Medical Oncology, Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, London, UK.
  • Sanchez E; Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA.
  • Rassy E; Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University of London, London, UK.
  • Boussios S; Department of Urology, Medway NHS Foundation Trust, Windmill Road, ME7 5NY, Gillingham, Kent, UK.
Curr Cancer Drug Targets ; 23(6): 433-446, 2023.
Article en En | MEDLINE | ID: mdl-36757037
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Antineoplásicos Límite: Female / Humans Idioma: En Revista: Curr Cancer Drug Targets Asunto de la revista: ANTINEOPLASICOS / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Antineoplásicos Límite: Female / Humans Idioma: En Revista: Curr Cancer Drug Targets Asunto de la revista: ANTINEOPLASICOS / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido